StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

ALX Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ALX Oncology's price to book ratio was 1.1× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 4.5×, with a median of 1.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−0.2
2025Dec 31, 20251.4×+0.7
2024Dec 31, 20240.6×−3.0
2023Dec 29, 20233.6×+2.0
2022Dec 30, 20221.6×−0.7
2021Dec 31, 20212.3×−10.4
2020Dec 31, 202012.7×–

More ALX Oncology figures

See a number that looks wrong?